Srdjan Vukovic
Srdjan Vukovic was appointed as a Class II Director
Highest-materiality recent filing
SelectQuote Q3 FY2026 revenue $430.9M, net income $40.2M, reaffirms FY guidance
Revenue $430.9M (up from $408.2M YoY); net income $40.2M vs $26.0M.
SelectQuote stock price below $1.00 triggers NYSE non-compliance notice; cure period six months
NYSE notice: avg closing price <$1.00 over 30 consecutive trading days; six-month cure period to regain compliance.
SelectQuote Q2 revenue $537M, net income $69.3M; cuts FY guidance on carrier, PBM headwinds
Revenue $537.1M vs $481.1M YoY; net income $69.3M vs $53.2M; Adj. EBITDA $84.7M vs $87.5M.
SelectQuote closes $415M credit facility with Pathlight and UMB, extends maturity to 2031
New $325M term loan (Pathlight) and $90M revolver (UMB) replace prior facilities; $313.8M used to repay existing debt.
SelectQuote stockholders elect Devine and Hawks as Class III directors; ratify Deloitte as auditor
Denise L. Devine re-elected with 65.4M votes for, 17.7M withheld; 31.4M broker non-votes.
SelectQuote Q1 FY2026 revenue $328.8M, net loss narrows to $30.5M but adj EBITDA plunges to -$32.1M
Revenue $328.8M vs $292.3M YoY; net loss $30.5M vs $44.5M YoY.
SelectQuote reports Q4 revenue $345.1M, net income $12.9M; FY26 revenue guidance $1.65B-$1.75B
Revenue $345.1M (+12% YoY); net income $12.9M vs net loss $31.0M in Q4 FY2024.
SelectQuote Q4 FY2025 revenue up 12% to $345M; net income of $12.9M vs prior year loss
Revenue $345.1M (+12% YoY); net income $12.9M vs net loss -$31.0M in Q4 FY2024.
SelectQuote extends revolving facility termination date to September 30, 2027
Revolving facility termination date extended from June 30, 2026 to September 30, 2027.
SelectQuote Vice Chairman Tom Grant dies; sons Bill and Bob remain in executive roles
William T. (Tom) Grant II, Vice Chairman and former President, passed away July 1, 2025 after a battle with cancer.
SelectQuote Q3 revenue $408.2M, net income $26.0M; guides FY25 EBITDA $115M-$140M
Revenue $408.2M (+8.5% YoY); net income $26.0M vs $8.6M YoY.
SelectQuote closes $350M preferred stock and warrant investment from Morgan Stanley and Bain Capital
Morgan Stanley and Bain each invested $175M for 175,000 preferred shares and warrants in three tranches on Feb 28, 2025.
SelectQuote raises $350M via preferred stock, reports Q2 net income $53.2M
$350M aggregate investment from Morgan Stanley and Bain in Senior Non-Convertible Preferred Stock and warrants.
SelectQuote stockholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting
Elected Earl H. 'Trace' Devanny III (65.4M for, 9.4M withheld) and Raymond F. Weldon (65.2M for, 9.5M withheld) as Class II directors.
SelectQuote Q1 FY2025 revenue $292.3M, net loss $44.5M, Adj EBITDA $(1.7)M
Revenue of $292.3M, up 26% YoY from $232.7M; net loss widened to $44.5M from $31.1M.
SelectQuote subsidiary issues $100M in asset-backed notes secured by commissions
$60M Class A 7.80% notes and $40M Class B 9.65% notes issued by subsidiary SQ ABS Issuer, LLC.
SelectQuote completes $100M securitization, extends term debt maturity to Sept 2027
Issued $60M of 7.80% Class A notes and $40M of 9.65% Class B notes in ABS facility.
SelectQuote Q4 FY2024 revenue $307M, Adj EBITDA $14.4M; FY2025 Adj EBITDA guidance $90-120M
Q4 revenue $307.2M (up from $221.8M YoY); net loss narrowed to $31.0M from $47.8M.
SelectQuote Q3 revenue up 26% YoY to $376M; raises FY2024 guidance
Revenue $376.4M vs $299.4M YoY; net income $8.6M vs $9.3M YoY.
Srdjan Vukovic was appointed as a Class II Director
Christopher Wolfe was appointed as a Class I Director
Max materiality 0.85 · Median 0.75 · Most common event earnings